<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE us-patent-application SYSTEM "us-patent-application-v43-2012-12-04.dtd" [ ]><us-patent-application lang="EN" dtd-version="v4.3 2012-12-04" file="US20140005216A1-20140102.XML" status="PRODUCTION" id="us-patent-application" country="US" date-produced="20131218" date-publ="20140102"><us-bibliographic-data-application lang="EN" country="US"><publication-reference><document-id><country>US</country><doc-number>20140005216</doc-number><kind>A1</kind><date>20140102</date></document-id></publication-reference><application-reference appl-type="utility"><document-id><country>US</country><doc-number>13928317</doc-number><date>20130626</date></document-id></application-reference><us-application-series-code>13</us-application-series-code><classifications-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>A</section><class>61</class><subclass>K</subclass><main-group>31</main-group><subgroup>485</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr></classifications-ipcr><classifications-cpc><main-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>A</section><class>61</class><subclass>K</subclass><main-group>31</main-group><subgroup>485</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc></main-cpc></classifications-cpc><classification-national><country>US</country><main-classification>514282</main-classification></classification-national><invention-title id="d0e43">Nalmefene for reduction of alcohol consumption in specific target populations</invention-title><us-related-documents><us-provisional-application><document-id><country>US</country><doc-number>61788810</doc-number><date>20130315</date></document-id></us-provisional-application><us-provisional-application><document-id><country>US</country><doc-number>61736740</doc-number><date>20121213</date></document-id></us-provisional-application><us-provisional-application><document-id><country>US</country><doc-number>61721539</doc-number><date>20121102</date></document-id></us-provisional-application><us-provisional-application><document-id><country>US</country><doc-number>61664804</doc-number><date>20120627</date></document-id></us-provisional-application></us-related-documents><us-parties><us-applicants><us-applicant sequence="00" app-type="applicant" designation="us-only" applicant-authority-category="assignee"><addressbook><orgname>H. Lundbeck A/S</orgname><address><city>Valby-Copenhagen</city><country>DK</country></address></addressbook><residence><country>DK</country></residence></us-applicant></us-applicants><inventors><inventor sequence="00" designation="us-only"><addressbook><last-name>Torup</last-name><first-name>Lars</first-name><address><city>Vaerlose</city><country>DK</country></address></addressbook></inventor><inventor sequence="01" designation="us-only"><addressbook><last-name>Abbariki</last-name><first-name>Afsaneh</first-name><address><city>Holte</city><country>DK</country></address></addressbook></inventor><inventor sequence="02" designation="us-only"><addressbook><last-name>Bladstr&#xf6;m</last-name><first-name>Anna</first-name><address><city>Lund</city><country>SE</country></address></addressbook></inventor><inventor sequence="03" designation="us-only"><addressbook><last-name>Persson</last-name><first-name>Christine</first-name><address><city>Lund</city><country>SE</country></address></addressbook></inventor><inventor sequence="04" designation="us-only"><addressbook><last-name>Meulien</last-name><first-name>Didier</first-name><address><city>Boulogne Billancourt</city><country>FR</country></address></addressbook></inventor><inventor sequence="05" designation="us-only"><addressbook><last-name>S&#xf8;rensen</last-name><first-name>Per</first-name><address><city>Kobenhavn O</city><country>DK</country></address></addressbook></inventor><inventor sequence="06" designation="us-only"><addressbook><last-name>Jensen</last-name><first-name>Thomas Jon</first-name><address><city>Virum</city><country>DK</country></address></addressbook></inventor><inventor sequence="07" designation="us-only"><addressbook><last-name>&#xd8;stergaard</last-name><first-name>Jette Buch</first-name><address><city>Kobenhavn N</city><country>DK</country></address></addressbook></inventor></inventors></us-parties></us-bibliographic-data-application><abstract id="abstract"><p id="p-0001" num="0000">The present invention relates to nalmefene for use in the reduction of alcohol consumption in a patient with alcohol dependence who has a high drinking risk level. The present invention also relates to nalmefene for use in the reduction of alcohol consumption in a patient with alcohol dependence who maintains at least medium DRL after an observation period following initial assessment.</p></abstract></us-patent-application>